Cyclosporine Ophthalmic Solution (VEVYE)
Calcineurin Inhibitor Immunosuppressant class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Cyclosporine Ophthalmic Solution used for?
Cyclosporine Ophthalmic Solution is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Cyclosporine Ophthalmic Solution?
No. Cyclosporine Ophthalmic Solution is brand-only with no generic equivalents currently in market.
How much does my plan pay for Cyclosporine Ophthalmic Solution?
Across 329 Part D plans, Cyclosporine Ophthalmic Solution averages $379.87/unit (NADAC). Lowest available: $379.87/unit. Highest in distribution: $379.87/unit.
Is Cyclosporine Ophthalmic Solution on the FDA shortage list?
No. Cyclosporine Ophthalmic Solution is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.